TSLX Q1 2026 Earnings EPS Misses by Over 23 Yet Stock Gains Slightly NKE Q1 2026 Earnings Strong EPS Beat Amidst Uncertain Revenue Landscape Verrica Pharmaceuticals Q1 2026 Earnings EPS Miss Amid PreRevenue Stage Stock Rises 271 ASUR Q1 2026 Earnings EPS Surpasses Estimates by 183 Recurring Revenue Growth Drives Profitability SHW Q1 2026 Earnings EPS Beats Estimates but Stock Slips Slightly NWBI Q1 2026 Earnings Earnings Surpass Estimates as Stock Declines Amid Broader Market Pressure